Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:54 pm Sale | 2024-09-30 | 13G | Iterum Therapeutics plc ITRM | Point72 Asset Management L.P. | 0 0.000% | -850,001 (Position Closed) | Filing History |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | Iterum Therapeutics plc ITRM | Armistice Capital, LLC | 1,340,000 6.030% | 1,340,000 (New Position) | Filing History |
| 2024-01-31 4:55 pm Purchase | 2024-01-30 | 13G | Iterum Therapeutics plc ITRM | Point72 Asset Management L.P. | 850,001 6.300% | 850,001 (New Position) | Filing History |
| 2022-01-03 5:30 pm Sale | 2021-12-31 | 13G | Iterum Therapeutics plc ITRM | SABBY MANAGEMENT LLC | 0 0.000% | -516,667 (Position Closed) | Filing History |
| 2021-02-12 5:22 pm Purchase | 2020-12-31 | 13D | Iterum Therapeutics plc ITRM | New Leaf Venture Management III L.L.C. | 355,453 4.500% | 257,617 (+263.31%) | Filing History |
| 2021-02-12 5:01 pm Sale | 2021-02-11 | 13D | Iterum Therapeutics plc ITRM | Sarissa Capital Management LP | 0 0.000% | -1,286,185 (Position Closed) | Filing History |
| 2021-02-11 4:46 pm Sale | 2021-02-09 | 13G | Iterum Therapeutics plc ITRM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -915,358 (Position Closed) | Filing History |
| 2021-02-10 3:40 pm Purchase | 2020-07-01 | 13D | Iterum Therapeutics plc ITRM | Advent Life Sciences LLP | 192,672 3.500% | 134,046 (+228.64%) | Filing History |
| 2021-02-10 2:27 pm Purchase | 2021-02-10 | 13G | Iterum Therapeutics plc ITRM | SABBY MANAGEMENT LLC | 516,667 11.000% | 516,667 (New Position) | Filing History |
| 2021-02-09 5:02 pm Sale | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | Pivotal bioVenture Partners Fund I L.P. | 63,006 1.200% | -0 (-0.00%) | Filing History |
| 2021-02-08 5:16 pm Purchase | 2021-02-04 | 13G | Iterum Therapeutics plc ITRM | RA CAPITAL MANAGEMENT L.P. | 915,358 10.600% | 248,692 (+37.30%) | Filing History |
| 2021-02-03 2:37 pm Unchanged | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | CANAAN X L.P. | 115,545 4.000% | 0 (Unchanged) | Filing History |
| 2021-01-29 06:32 am Sale | 2020-12-31 | 13G | Iterum Therapeutics plc ITRM | Mitchell P. Kopin | 171,852 4.990% | -7,802 (-4.34%) | Filing History |
| 2020-12-02 4:31 pm Purchase | 2020-11-22 | 13G | Iterum Therapeutics plc ITRM | RA CAPITAL MANAGEMENT L.P. | 666,667 18.900% | 666,667 (New Position) | Filing History |
| 2020-11-23 5:02 pm Purchase | 2020-11-22 | 13D | Iterum Therapeutics plc ITRM | Sarissa Capital Management LP | 1,286,185 30.950% | 1,286,185 (New Position) | Filing History |
| 2020-11-10 09:02 am Unchanged | 2020-10-30 | 13G | Iterum Therapeutics plc ITRM | Wellington Management Group LLP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-11-02 06:26 am Purchase | 2020-10-22 | 13G | Iterum Therapeutics plc ITRM | Mitchell P. Kopin | 179,654 6.800% | 179,654 (New Position) | Filing History |
| 2020-10-29 1:00 pm Unchanged | 2020-10-27 | 13D | Iterum Therapeutics plc ITRM | Frazier Healthcare VII L.P. | 103,811 4.200% | 0 (Unchanged) | Filing History |
| 2020-07-10 4:19 pm Purchase | 2020-06-30 | 13G | Iterum Therapeutics plc ITRM | Armistice Capital, LLC | 74,276 4.990% | 14,867 (+25.02%) | Filing History |
| 2020-07-06 2:36 pm Purchase | 2020-06-30 | 13D | Iterum Therapeutics plc ITRM | Frazier Healthcare VII L.P. | 103,811 7.300% | 1,256 (+1.22%) | Filing History |